MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/cncr.70238

Медицинская библиотека · Cancer · 2026

Molecular alteration profiles characterize intraductal carcinoma of the prostate.

Dudipala Harshitha, Nazari Shayan S, Werneck da Cunha Isabela, Coligado Nathan, Baca Yasmine, Wei Shuanzeng, Elliott Andrew, Smith Norm D, Geynisman Daniel M, Brown Jacqueline T, Zarrabi Kevin K, Agarwal Neeraj, Antonarakis Emmanuel S, Herchenhorn Daniel, McKay Rana R

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Intraductal carcinoma of the prostate (IDC-P) is an intra-acinar and/or intraductal neoplastic epithelial proliferation that is a distinct histological entity according to the 2016 World Health Organization (WHO) classification system. Clinically, it is associated with higher grade tumors and a more aggressive disease course. However, the molecular underpinnings of IDC-P are not well elucidated.

METHODS

This study identified radical prostatectomy (RP) cases from the Caris Life Sciences database, classified as prostatic adenocarcinoma with grade group 4/5 or with the words "cribriform," "necrosis," or "intraductal" in the pathology report. Digitized hematoxylin-eosin slides underwent central pathology review by a board-certified genitourinary pathologist to identify the presence of IDC-P according to the 2022 WHO classification. IDC-P cases (n = 175) were compared to non-IDC-P cases (n = 5334). Prostatic tumor specimens were sequenced via next-generation DNA/RNA sequencing.

RESULTS

Compared to non-IDC-P cases, the IDC-P cohort had significantly more mutations in MUTYH (4.5% vs. 1.4%; p < .01), FANCA (2.7% vs. 0.5%; p < .01), NBN (2.5% vs. 0.6%; p < .05), and MTOR (0.6% vs. 0.1%; p < .05). IDC-P tumors were enriched for DLL3 and CEACAM5 expression, with lower expression of STEAP1, TROP2, ERBB2, PSCA, and B7-H3, compared to non-IDC-P tumors. IDC-P had significantly higher neuroendocrine prostate cancer signature scores and IFN-γ signature scores, and similar androgen receptor signature scores, compared to non-IDC-P. The tumor microenvironment of IDC-P had significantly higher cell fractions of M2 macrophages and fewer dendritic cells.

CONCLUSIONS

IDC-P possesses a distinct molecular and immunological profile. Understanding these molecular underpinnings is crucial for the development of personalized treatment strategies for histologically distinct prostate cancer subsets.

Для цитирования: Dudipala Harshitha, Nazari Shayan S, Werneck da Cunha Isabela, Coligado Nathan, Baca Yasmine, Wei Shuanzeng, Elliott Andrew, Smith Norm D, Geynisman Daniel M, Brown Jacqueline T, Zarrabi Kevin K, Agarwal Neeraj, Antonarakis Emmanuel S, Herchenhorn Daniel, McKay Rana R. Molecular alteration profiles characterize intraductal carcinoma of the prostate.. Cancer. 2026. DOI: 10.1002/cncr.70238.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.